*Company- Influx Healthtech* *Product Summary- Influx Healthtech एक फार्मा मैन्युफैक्चरिंग कंपनी है जो अलग-अलग इंडस्ट्री के लिए कॉन्ट्रैक्ट मैन्युफैक्चरिंग के तहत दवाइया बनाती है* Date- June 18, 2025, to June 20, 2025 Price- ₹96 per share Total Issue Size- 55.63 Crore Fresh Issue- 45.07 Crore Offer for Sale- 10.56 Crore Anchor Investment- Allotted Shares worth 15.83 cores to Anchor investors, some of the important names are as follows: - CCV EMERGING OPPORTUNITIES FUND-1 - FINAVENUE CAPITAL TRUST - CRAFT EMERGING MARKET FUND PCC- - PERSISTENT GROWTH FUND - BEACON STONE CAPITAL VCC - AARTH AIF GROWTH FUND - VIKASA INDIA EIF I FUND - VBCUBE VENTURES FUND Lot Size (Retail)- 1200 Shares Application Size (Retail)- 1,15,200 Lot Size (HNI)- 2400 Shares Application Size (HNI)- Rs 2,23,400 *Revenue and Profit Details:* Period Ended 31-Mar-25 31-Mar-24 31-Mar-23 Revenue 104.99 100.1 76.07 Profit After Tax 13.37 11.22 7.2 Debt- 22 Lac Debt to Equity- 0.01 Overall Financials: - Revenue and profit growth is Average over the years - Debt to Equity ratio is very good Company Valuation and Peer to peer Comparison- The company has shown following company listed peers Company Name P/E (x) Sudarshan Pharma Industries Ltd 48.28 Quest Laboratories Limited 10.38 The company Influx Healthtech is coming at 16.63 PE which seems to be affordable Product Market Fit: कॉन्ट्रैक्ट मैन्युफैक्चरिंग जैसी एक्टिविटी की भारत में अच्छी डिमांड है Customer Base: - Pharma Companies Lead Manager- Rarever Financial Advisor - First IPO to be managed in 2025 Market Maker- R.K. Stock holding Private Limited - First IPO to be managed in 2025